An update on genetic analysis of cholestatic liver diseases: Digging deeper

Digestive Diseases

Volumn 29, Issue 1, 2011, Pages 72-77

  Müllenbach, Roman ^a   Lammert, Frank ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

ABC transporters; Genome wide scan; Personalized medicine; Polygenic disease

Indexed keywords

CHOLESTASIS; CONFERENCE PAPER; DISEASE PREDISPOSITION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 1; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTASIS, INTRAHEPATIC; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHERITANCE PATTERNS; PHENOTYPE;

EID: 79959518499     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000324137     Document Type: Conference Paper

References (37)

1. Getting personal. Nature 2008; 455:1007.
2. European Society of Human Genetics: Statement of the ESHG on di rect-to-consumer genetic testing for health-related purposes. Eur J Hum Genet 2010; 18: 1271-1273.
3. Positively disruptive. Nat Genet 2008; 40:119.
4. Krawczyk M, Müllenbach R, Weber SN, et al: Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol 2010; 7:669-681.
5. Oda T, Elkahloun AG, Pike BL, et al: Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997; 16: 235-242.
6. Kamath BM, Krantz ID, Spinner NB, et al: Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance. Am J Med Genet 2002; 112: 194-197. (Pubitemid 35332186)
7. Gissen P, Tee L, Johnson CA, et al: Clinical and molecular genetic features of ARC syndrome. Hum Genet 2006; 120: 396-409. (Pubitemid 44400474)
8. Cullinane AR, Straatman-Iwanowska A, Zaucker A, et al: Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization. Nat Genet 2010; 42: 303-312.
9. Deleuze JF, Jacquemin E, Dubuisson C, et al: Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996; 23: 904-908. (Pubitemid 26112008)
10. Bull LN, van Eijk MJ, Pawlikowska L, et al: A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998; 18: 219-224. (Pubitemid 28117258)
11. Strautnieks SS, Bull LN, Knisely AS, et al: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-238. (Pubitemid 28507666)
12. Jacquemin E, De Vree JM, Cresteil D, et al: The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120:1448-1458. (Pubitemid 32322319)
13. Strautnieks SS, Byrne JA, Pawlikowska L, et al: Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008; 134: 1203-1214.
14. Paulusma CC, Groen A, Kunne C, et al: Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 2006; 44: 195-204. (Pubitemid 44049152)
15. Verhulst PM, van der Velden LM, Oorschot V, et al: A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells. Hepatology 2010; 51: 2049-2060.
16. Ray NB, Durairaj L, Chen BB, et al: Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat Med 2010; 16:1120-1127.
17. Smit JJ, Schinkel AH, Oude Elferink RP, et al: Homozygousdisruption of the murinemdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-462. (Pubitemid 23335071)
18. Pawlikowska L, Strautnieks S, Jankowska I, et al: Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol 2010; 53: 170-178.
19. Davit-Spraul A, Fabre M, Branchereau S, et al: ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl trans-ferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 2010; 51: 1645-1655.
20. Dixon PH, Weerasekera N, Linton KJ, et al: Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9: 1209-1217. (Pubitemid 30248607)
21. Müllenbach R, Linton KJ, Wiltshire S, et al: ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40:e70.
22. Savander M, Ropponen A, Avela K, et al: Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003; 52: 1025-1029. (Pubitemid 36765296)
23. Wasmuth HE, Glantz A, Keppeler H, et al: Intrahepatic cholestasis of pregnancy: the severe form is associated with common va riants of the hepatobiliary phospholipid transpor ter ABCB4 gene. Gut 2007; 56: 265-270.
24. Knisely AS, Strautnieks SS, Meier Y, et al: Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 2006; 44: 478-486. (Pubitemid 44214888)
25. Byrne JA, Strautnieks SS, Ihrke G, et al: Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 2009; 49:553-567.
26. Ho RH, Leake BF, Kilkenny DM, et al: Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics 2010; 20: 45-57.
27. Müllenbach R, Lammert F: The transporter 'variome': the missing link between gene variants and bile salt transporter function. Hepatology 2009; 49: 352-354.
28. Hayashi H, Sugiyama Y: 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps. Hepatology 2007; 45: 1506-1516. (Pubitemid 46918335)
29. Van der Velden LM, Stapelbroek JM, Krieger E, et al: Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate. Hepatology 2010; 51: 286-296.
30. Meier Y, Pauli-Magnus C, Zanger UM, et al: Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology 2006; 44: 62-74. (Pubitemid 44049139)
31. Lang C, Meier Y, Stieger B, et al: Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 2007; 17: 47-60. (Pubitemid 46183791)
32. Meier Y, Zodan T, Lang C, et al: Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T 1C polymorphism in the bile salt export pump. World J Gastroenterol 2008; 14:38-45. (Pubitemid 351314324)
33. Dixon PH, van Mil SW, Chambers J, et al: Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009; 58: 537-544.
34. Hirschfield GM, Liu X, Xu C, et al: Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360:2544-2555.
35. * 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41: 816 - 819.
36. Liu X, Invernizzi P, Lu Y, et al: Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010; 42:658-660.
37. Zimmer V, Müllenbach R, Simon E, et al: Combined funct iona l variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy. Liver Int 2009; 29:1286-1288.